• Description
  • Programmes
  • Contact

Sectors: Health, Industry, Innovation, Research

Beneficiaries: Corporations, Development NGOs, Non-profit organisations, Research centres, Schools, SMEs, Universities

Regions: Asia, Balkans, Candidate countries, European Economic Area, European Union, Mediterranean countries, Worldwide

Category: Call for proposals

References:

To view this information, please connect.

Additional info regions:

Developing countries: Over 100 developing countries are automatically eligible for funding under Horizon 2020

Responsible: European Commission

Useful:

To view this information, please connect.

Contact:

To view this information, please connect.

Advice:

To view this information, please connect.

Amorce:

This call for proposals aims to reward the person or team who can most effectively meet the following challenge: develop a rapid test that will allow healthcare providers to distinguish, at the point of care, between patients with upper respiratory tract infections that require antibiotics and those that can be treated safely without antibiotics.

Priorities and funded actions:

Objectives
– To reduce the unnecessary use of antibiotics in case of viral upper respiratory tract infections
– To reduce costs and side effects linked to the use of antibiotics
– To delay the emergence of antibiotic resistant organisms
– To enable health-care providers to take early decisions in the management of upper respiratory tract infections (rapid initiation and cessation of treatment) and to facilitate the health care provider’s decision not to prescribe antibiotics in case of viral infections and to facilitate patients’ acceptance of not taking antibiotics for viral infections
– To tackle the widespread and significant health care issue of respiratory infections; an ageing population, antibiotic resistance and increasing health care costs make this a particularly challenging problem

Among financed actions
– Development of a rapid point of care test that will reduce the use of antibiotics in a safe way in patients with upper respiratory tract infections